Endothelial nitric oxide (NO) synthase (eNOS) has an indispensable role in the erectile response. In the penis, eNOS activity and endothelial NO bioavailability are regulated by multiple post-translatlonal molecular mechanisms, such as eNOS phosphorylation, eNOS interaction with regulatory proteins and contractile pathways, and actions of reactive oxygen species (ROS). These mechanisms regulate eNOS-mediated responses under physiologic circumstances and provide various mechanisms whereby endothelial NO availability may be altered in states of vasculogenlc erectile dysfunction (ED), in view of the recent advances in the field of eNOS function in the penis and its role in penile erection, the emphasis in this review is placed on the mechanisms regulating eNOS activity and its interaction with the RhoA/Rho-kinase pathway in the physiology of penile erection and the pathophysiology of ED.
IgnarroU, BushPA, BugaGM, WoodKS, FukutoJM, RajferJ. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun170: 843–850, 1990.
2.
BurnettAL, LowensteinCJ, BredtDS, ChangTS, SnyderSH. Nitric oxide: a physiologic mediator of penile erection. Science257: 401–403, 1992.
3.
BusseR, MulschA. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett265: 133–136, 1990.
4.
DimmelerS, FlemingI, FisslthalerB, HermannC, BusseR, ZeiherAM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature399: 601–605, 1999.
5.
FultonD, GrattonJP, McCabeTJ, FontanaJ, FujioY, WalshK, FrankeTF, PapapetropoulosA, SessaWC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature399: 597–601, 1999.
6.
MichellBJ, GriffithsJE, MitchelhillKI, Rodriguez-CrespoI, TiganisT, BozinovskiS, de MontellanoPR, KempBE, PearsonRB. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol9: 845–848, 1999.
7.
BauerPM, FultonD, BooYC, SorescuGP, KempBE, JoH, SessaWC. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric oxide synthase. J Biol Chem278: 14841–14849, 2003.
8.
BooYC, SorescuG, BoydN, ShiojimasI, WalshK, DuJ, JoH. Shear stress stimulates phosphorylation of endothelial nitric oxide-synthase at Ser 1179 by Akt-independent mechanisms. Role of protein kinase A. J Biol Chem277: 3388–3396, 2002.
9.
SessaWC. eNOS at a glance. J Cell Sci117: 2427–2429, 2004.
10.
HurtKJ, MusickiB, PaleseMA, CroneJK, BeckerRE, MoriarityJL, SnyderSH, BurnettAL. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci U S A99: 4061–4066, 2002.
MichellBJ, HarrisMB, ChenZP, JuH, VenemaVJ, BlackstoneMA, HuangW, VenemaRC, KempBE. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem277: 42344–42351, 2002.
13.
BooYC, SorescuGP, BauerPM, FultonD, KempBE, HarrisonDG, SessaWC, JoH. Endothelial NO synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med35: 729–741, 2003.
14.
Garcia-CardenaG, FanR, ShahV, SorrentinoR, CirinoG, PapapetropoulosA, SessaWC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature392: 821–824, 1998.
15.
OuJ, FontanaJT, OuZ, JonesDW, AckermanAW, OldhamKT, YuJ, SessaWC, PritchardKAJr.Heat shock protein 90 and tyrosine kinase regulate eNOS NO* generation but not NO* bioactivity. Am J Physiol Heart Circ Physiol286: H561–H569, 2004.
16.
PritchardKAJr, AckermanAW, GrossER, SteppDW, ShiY, FontanaYT, BakerJE, SessaWC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem276: 17621–17624, 2001.
17.
HarrisMB, JuH, VenemaVJ, LiangH, ZouR, MichellBJ, ChenZP, KempBE, VenemaRC. Reciprocal phosphorylation and regulation of endothelial nitric oxide-synthase in response to bradykinin stimulation. J Biol Chem276: 16587–16591, 2001.
18.
MichellBJ, ChenZ, TiganisT, StapletonD, KatsisF, PowerDA, SimAT, KempBE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and cAMP-dependent protein kinase. J Biol Chem276: 17625–17628, 2001.
BooYC, HwangJ, SykesM, MichellBJ, KempBE, LumH, JoH. Shear stress stimulates phosphorylation of eNOS at Ser 635 by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol283: H1819–H1828, 2002.
21.
MusickiB, KramerMF, BeckerRE, BurnettAL. Age-related changes in phosphorylation of endothelial nitric oxide synthase in the rat penis. J Sex Med2: 347–357, 2005.
22.
SommerF, KlotzT, SteinritzD, SchmidtA, AddicksK, EngelmannU, BlochW. MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum. Int J Impot Res14: 217–225, 2002.
23.
Garcia-CardenaG, OhP, LiuJ, SchnitzerJE, SessaWC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A93: 6448–6453, 1996.
MichelJB, FeronO, SacksD, MichelT. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem272: 15583–15586, 1997.
26.
BucciM, GrattonJP, RudicRD, AcevedoL, RoviezzoF, CirinoG, SessaWC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med6: 1362–1367, 2000.
27.
NishidaCR, Ortiz de MontellanoPR. Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element. J Biol Chem274: 14692–14698, 1999.
TeixeiraCE, MorenoRA, FerreiraU, Rodrigues NettoNJr, FregonesiA, AntunesE, De NucciG. Pharmacological characterization of kinin-induced relaxation of human corpus cavernosum. Br J Urol81: 432–436, 1998.
30.
UehataM, IshizakiT, SatohH, OnoT, KawaharaT, MorishitaT, TamakawaH, YamagamiK, InuiJ, MaekawaM, NarumiyaS. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature389: 990–994, 1997.
31.
FengJ, ItoM, IchikawaK, IsakaN, NishikawaM, HartshorneDJ, NakanoT. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem274: 37385–37390, 1999.
32.
SauzeauV, Le JeuneH, Cario-ToumaniantzC, SmolenskiA, LohmannSM, BertoglioJ, ChardinP, PacaudP, LoirandG. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem275: 21722–21729, 2000.
33.
MingXF, ViswambharanH, BarandierC, RuffieuxJ, KaibuchiK, RusconiS, YangZ. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol22: 8467–8477, 2002.
34.
ChitaleyK, WingardCJ, WebbRC, BranamH, StopperVS, LewisRW, MillsTM. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med7: 119–122, 2001.
WingardCJ, HusainS, WilliamsJ, JamesS. RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am J Physiol Regul Integr Comp Physiol285: R1145–R1152, 2003.
37.
MillsTM, ChitaleyK, LewisRW, WebbRC. Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection. Eur J Pharmacol439: 173–174, 2002.
38.
BivalacquaTJ, ChampionHC, UstaMF, CellekS, ChitaleyK, WebbRC, LewisRL, MillsTM, HellstromWJ, KadowitzPJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A101: 9121–9126, 2004.
39.
ReesRW, RalphDJ, RoyleM, MoncadaS, CellekS. Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol133: 455–458, 2001.
40.
TeixeiraCE, YingZ, WebbRC. Pro-erectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-melhyl-5-isoquinolinyl)sulfonyl]ho-mopiperazine (H-1152) in the rat penis. J Pharmacol Exp Ther315: 155–162, 2005.
41.
ChitaleyK, BivalacquaTJ, ChampionHC, UstaMF, HellstromWJ, MillsTM, WebbRC. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun298: 427–432, 2002.
42.
TouyzRM, SchiffrinEL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004122: 339–352, 2004.
43.
SchulzE, AnterE, KeaneyJFJr.Oxidative stress, antioxidants, and endothelial function. Curr Med Chem11: 1093–1104, 2004.
44.
BivalacquaTJ, ArmstrongJS, BiggerstaffJ, Abdel-MageedAB, KadowitzPJ, HellstromWJ, ChampionHC. Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol284: H1408–H1421, 2003.
45.
JinL, YingZ, WebbRC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol287: H1495–H1500, 2004.
46.
MeulemanEJ. Prevalence of erectile dysfunction: need for treatment?Int J Impot Res14 (Suppl 1): S22–S28, 2002.
47.
GarbanH, VernetD, FreedmanA, RajferJ, Gonzalez-CadavidN. Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol268: H467–H475, 1995.
48.
HaasC, SeftelAD, RazmjoueiK, GanzMB, HampelN, FergusonK. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology51: 516–522, 1998.
49.
BakirciogluME, SievertKD, NunesL, LauA, LinCS, LueTF. Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol166: 734–738, 2001.
50.
Gonzalez-CadavidNF, RajferJ. Molecular pathophysiology and gene therapy of aging-related erectile dysfunction. Exp Gerontol39: 1705–1712, 2004.
51.
SeftelAD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol169: 1999–2007, 2003.
52.
ChampionHC, BivalacquaTJ, HymanAL, IgnarroLJ, HellstromWJ, KadowitzPJ. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A96: 11648–11652, 1999.
53.
LinCS, LiuX, ChowS, LueTF. Cyclic AMP and cyclic GMP activate protein kinase G in cavernosa! smooth muscle cells: old age is a negative factor. BJU Int89: 576–582, 2002.
54.
MusickiB, ChampionHC, BeckerRE, LiuT, KramerMF, BurnettAL. Erection capability is potentiated by chronic sildenafil treatment: role of blood flow-induced endothelial nitric oxide synthase phosphorylation. Mol Pharmacol68: 226–232, 2005.
55.
SakaiY, MasudaH, KiharaK, KurosakiE, YamauchiY, AzumaH. Involvement of increased arginase activity in impaired cavernous relaxation with aging in the rabbit. J Urol172: 369–373, 2004.
56.
MoodyJA, VernetD, LaidlawS, RajferJ, Gonzalez-CadavidN. Effect of long-term oral administration of L-arginine on the rat erectile response. J Urol158: 942–947, 1997.
57.
FerriniM, MageeTR, VernetD, RajferJ, Gonzalez-CadavidNF. Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis. Biol Reprod64: 974–982, 2001.
58.
RajasekaranM, KasyanA, JainA, KimSW, MongaM. Altered growth factor expression in the aging penis: the Brown-Norway rat model. J Androl23: 393–399, 2002.
59.
RajasekaranM, WhiteS, BaquirA, WilkesN. Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats. J Androl26: 182–188, 2005.
60.
HakimLS, GoldsteinI. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am25: 379–400, 1996.
61.
Saenz de TejadaI, GoldsteinI, AzadzoiK, KraneRJ, CohenRA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med320: 1025–1030, 1989.
62.
CellekS, FoxwellNA, MoncadaS. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes52: 2353–2362, 2003.
63.
PodlasekCA, ZelnerDJ, BervigTR, GonzalezCM, McKennaKE, McVaryKT. Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J Urol166: 746–755, 2001.
64.
BivalacquaTJ, UstaMF, ChampionHC, LeungwattanakijS, DabischPA, McNamaraDB, KadowitzPJ, HellstromWJ. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res16: 21–29, 2004.
65.
ChangS, HypoliteJA, VelezM, ChangolkarA, WeinAJ, ChackoS, DiSantoME. Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol287: R950–960, 2004.
66.
BivalacquaTJ, UstaMF, ChampionHC, AdamsD, NamaraDB, Abdel-MageedAB, KadowitzPJ, HellstromWJ. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol169: 1911–1917, 2003.
67.
BivalacquaTJ, HellstromWJG, KadowitzPJ, ChampionHC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun283: 923–927, 2001.
68.
YildirimS, AyanS, SariogluY, GultekinY, ButunerC. The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int83: 679–685, 1999.
69.
BivalacquaTJ, UstaMF, KendirciM, PradhanL, AlvarezX, ChampionHC, KadowitzPJ, HellstromWJG. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med2: 187–198, 2005.
70.
RyuJK, KimDJ, LeeT, KangYS, YoonSM, SuhJK. The role of free radical in the pathogenesis of impotence in streptozotocin-induced diabetic rats. Yonsei Med J44: 236–241, 2003.
71.
TuncayenginA, BiriH, OnaranM, SenI, TuncayenginO, PolatF, ErbasD, BozkirliI. Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction. Int J Androl26: 250–254, 2003.
72.
De YoungL, YuD, BatemanRM, BrockGB. Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction. J Androl25: 830–836, 2004.
73.
GocmenC, SecilmisA, KumcuEK, ErtugPU, OnderS, DikmenA, BaysalF. Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Eur J Pharmacol398: 93–98, 2000.
74.
KhanMA, ThompsonCS, JeremyJY, MumtazFH, MikhailidisP, MorganRJ. The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation. BJU Int87: 98–103, 2001.
75.
KeeganA, CotterMA, CameronNE. Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats. Free Radic Biol Med27: 536–543, 1999.
76.
BastaG, SchmidtAM, De CaterinaR. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res63: 582–592, 2004.
77.
SeftelAD, VaziriND, NiZ, RazmjoueiK, FogartyJ, HampelN, PolakJ, WangRZ, FergusonK, BlockC, HaasC. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology50: 1016–1026, 1997.
78.
UstaMF, BivalacquaTJ, YangDY, RamanitharanA, SellDR, ViswanathanA, MonnierVM, Hei IstromWJ. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol170: 1437–1442, 2003.
79.
CartledgeJJ, EardleyI, MorrisonJF. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int87: 402–407, 2001.
80.
CellekS, QuW, SchmidtAM, MoncadaS. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia47: 331–339, 2004.
81.
BrownleeM. Biochemistry and molecular cell biology of diabetic complications. Nature414: 813–820, 2001.
82.
GanzMB, SeftelA. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol Endocrinol Metab278: E146–E152, 2000.
83.
NangleMR, CotterMA, CameronNE. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur J Pharmacol475: 99–106, 2003.
84.
WellsL, VossellerK, HartGW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science29. 1:2376–2378, 2001.
85.
MusickiB, KramerMF, BeckerRE, BurnettAL. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A102: 11870–11875, 2005.
86.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes54: 1615–1625, 2005.
87.
ChangS, HypoliteJA, ChangolkarA, WeinAJ, ChackoS, DiSantoME. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res15: 53–62, 2003.
88.
WeiM, MaceraCA, DavisDR, HornungCA, NankinHR, BlairSN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol140: 930–937, 1994.
89.
KimJH, KlyachkinML, SvendsenE, DaviesMG, HagenPO, CarsonCC3rd. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol151: 198–205, 1994.
90.
KimSC, KimIK, SeoKK, BaekKJ, LeeMY. Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits. Urol Res25: 341–346, 1997.
91.
KimSC. Hyperlipidemia and erectile dysfunction. Asian J Androl2: 161–166, 2000.
92.
AzadzoiKM, Saenz de TejadaI. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol146: 238–240, 1991.
93.
Behr-RousselD, BernabeJ, CompagnieS, RupinA, VerbeurenTJ, AlexandreL, GiulianoF. Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Atherosclerosis162: 355–362, 2002.
94.
SeoKK, YunHY, KimH, KimSC. Involvement of endothelial nitric oxide synthase in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit. J Androl20: 298–306, 1999.
95.
YesilliC, YamanO, AnafartaK. Effect of experimental hypercholesterolemia on cavernosal structures. Urology57: 1184–1188, 2001.
96.
GholamiSS, RogersR, ChangJ, HoHC, GrazziottinT, LinCS, LueTF. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol169: 1577–1581, 2003.
97.
NehraA, AzadzoiKM, MorelandRB, PabbyA, SirokyMB, KraneRJ, RobertJ, GoldsteinI, UclelsonD. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol159: 2229–2236, 1998.
98.
ShuklaN, JonesR, PersadR, AngeliniGD, JeremyJY. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol517: 224–231, 2005.
99.
BlairA, ShaulPW, YuhannaIS, ConradPA, SmartEJ. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem274: 32512–32519, 1999.
100.
FeronO, DessyC, MoniotteS, DesagerJP, BalligandJL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest103: 897–905, 1999.
101.
PritchardKA, AckermanAW, OuJ, CurtisM, SmalleyDM, FontanaJT, StemermanMB, SessaWC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med33: 52–62, 2002.
102.
ChavakisE, DernbachE, HermannC, MondorfUF, ZeiherAM, DimmeierS. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation24: 2102–2107, 2001.
103.
FlemingI, MohamedA, GalleJ, TurchanowaL, BrandesRP, FisslthalerB, BusseR. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res1: 897–906, 2005.
104.
RueckschlossU, GalleJ, HoltzJ, ZerkowskiH-R, MorawietzH. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antiatherosclerotic potential of HMG-CoA reductase inhibitor therapy. Circulation104: 1767–1772, 2001.
105.
GalleJ, MameghaniA, BolzSS, GambaryanS, GorgM, QuaschningT, RaffU, BarthH, SeiboldS, WannerC, PohlU. Oxidized LDL and its compound lysophosphatidylcholine potentiate Ang II-induced vasoconstriction by stimulation of RhoA. J Am Soc Nephrol14: 1471–1479, 2003.
106.
AhnTY, Gomez-CoronadoD, MartinezV, CuevasP, GoldsteinI, Saenz de TejadaI. Enhanced contractility of rabbit corpus cavernosum smooth muscle by oxidized low density lipoproteins. Int J Impot Res11: 9–14, 1999.
107.
KimSC, SeoKK, KimHW, LeeMY. The effects of isolated lipoproteins and triglyceride, combined oxidized low density lipoprotein (LDL) plus triglyceride, and combined oxidized LDL plus high density lipoprotein on the contractile and relaxation response of rabbit cavernous smooth muscle. Int J Androl23(Suppl 2):26–29, 2000.
108.
BurchardtM, BurchardtT, BaerL, KissAJ, PawarRV, ShabsighA, de la Taille, HayekOR, ShabsighR. Hypertension is associated with severe erectile dysfunction. J Urol164: 1188–1191, 2000.
109.
MulvanyMJ. Vascular remodelling of resistance vessels: can we define this?Cardiovasc Res41: 9–13, 1999.
110.
ToblliJE, StellaI, InerraF, FerderL, ZellerF, MazzaON. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertension13: 686–692, 2000.
111.
JiangR, ChenJH, JinJ, ShenW, LiQM. Ultrastructural comparison of penile cavernous tissue between hypertensive and normotensive rats. Int J Impot Res (Epub ahead of print), 2005.
112.
Behr-RousselD, GornyD, MevelK, CompagnieS, KernP, SivanV, BernabeJ, BedigianMP, AlexandreL, GiulianoF. Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol288: R276–R283, 2005.
113.
OkabeH, HaleTM, KumonH, HeatonJP, AdamsMA. The penis is not protected—in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res11: 133–140, 1999.
UshiyamaM, MoritaT, KuramochiT, YagiS, KatayamaS. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res27: 253–261, 2004.
116.
WilkesN, WhiteS, SteinP, BernieJ, RajasekaranM. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats. Int J Impot Res16: 187–194, 2004.
117.
DorranceAM, LewisRW, MillsTM. Captopril reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats. Int J Impot Res14: 494–497, 2002.
118.
HaleTM, OkabeH, BushfieldTL, HeatonJP, AdamsMA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol168: 348–354, 2002.
119.
TouyzRM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol90: 449–455, 2005.
120.
DasUN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-β to prevent human essential hypertension. Eur J Clin Nutr58: 195–203, 2004.
121.
ChitaleyK, WebbRC, DorranceAM, MillsTM. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res13(Suppl 5):S16–S20, 2001.
122.
EscrigA, MarinR, AbreuP, Gonzalez-MoraJL, MasM. Changes in mating behavior, erectile function, and nitric oxide levels in penile corpora cavernosa in streptozotocin-diabetic rats. Biol Reprod66: 185–189, 2002.
